Meeting
2012 Gastrointestinal Cancers Symposium
Prognostic effects of circulating markers of epithelial mesenchymal transition (EMT) in metastatic colorectal cancer patients.
Authors
Neeraj Nailesh Shah
University of Texas M. D. Anderson Cancer Center, Houston, TX
Neeraj Nailesh Shah , Christopher Hanyoung Lieu , Cristina Ivan , Michael J. Overman , Masayoshi Shimizu , Jeffrey Morris , Hai T. Tran , John Heymach , George Calin , Scott Kopetz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 30, 2012 (suppl 4; abstr 456)
DOI
10.1200/jco.2012.30.4_suppl.456
Abstract #
456
Poster Bd #
B27
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
Assessment of IL-6, IL-8, bFGF, PDGF-BB, and VEGF-A as prognostic and predictive biomarkers for anti-VEGF in metastatic colorectal cancer (mCRC).
First Author: Timothy Jay Price
Poster
2022 ASCO Annual Meeting
Combined IL-6 and IL-8 inhibition to overcome mesenchymal stem cell (MSC)-induced resistance to antimetastatic drugs in osteosarcoma.
First Author: S. Rubina Baglio
Poster
2022 ASCO Annual Meeting
Analysis of plasma angiogenesis factors on the efficacy of first-line (1L) chemotherapy (chemo) combined with biologics in RAS wild-type metastatic colorectal cancer (mCRC): Results from GI-SCREEN CRC Ukit study.
First Author: Satoshi Yuki
Poster
2022 ASCO Annual Meeting
Dapagliflozin associated to sacubitril/valsartan and relationship with cardioprotection in human cardiac cells exposed to doxorubicin and HER2-blocking agents through MyD88, NLRP3 mediated pathways.
First Author: Nicola Maurea